NOVARTIS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 102 USD | -0.86% |
|
-1.22% | +0.98% |
| 08:07am | NOVARTIS AG : Berenberg remains Neutral | ZD |
| 06:01am | Novartis' Cosentyx Receives Canadian Approval for Hidradenitis Suppurativa Treatment | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NOVARTIS AG | Other Pharmaceuticals | -0.86% | -1.22% | +0.98% | +1.21% | +21.51% | 208B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- NOVN Stock
- NVS Stock
- Charts Novartis AG
- Comparison Chart
